Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Lonza To Buy US Drug Capsules Maker Capsugel From KKR For $5.5B
Private Equity

Lonza To Buy US Drug Capsules Maker Capsugel From KKR For $5.5B

by reuters.com posted 1year ago 1811 views
<p>Lonza Group AG announced its biggest ever acquisition on Thursday with a deal to buy Capsugel, a U.S. maker of capsule products and other drug delivery systems, for $5.5 billion in cash to broaden its product range as a pharmaceuticals industry supplier.</p> <p>The Swiss company&#39;s shares fell by over 7 percent on the news to around 157 Swiss francs ($154) on concerns that the acquisition, costing over 60 percent of Lonza&#39;s market value, and a planned capital increase of up to 3.3 billion Swiss francs ($3.22 billion), would be hard to digest.</p>